• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SIGLEC1 (CD169) as a potential diagnostical screening marker for monogenic interferonopathies.

作者信息

Orak Banu, Ngoumou Gonza, Ebstein Frédéric, Zieba Barbara, Goetzke Carl Christoph, Knierim Ellen, Kaindl Angela M, Panzer Axel, Theophil Manuela, Berns Monika, Krüger Elke, Meisel Christian, Unterwalder Nadine, Kallinich Tilmann

机构信息

Pediatric Pneumology, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Center for Chronically Sick Children (SPZ), Charité - Universitätsmedizin Berlin, Berlin, Germany.

出版信息

Pediatr Allergy Immunol. 2021 Apr;32(3):621-625. doi: 10.1111/pai.13400. Epub 2020 Nov 9.

DOI:10.1111/pai.13400
PMID:33099809
Abstract
摘要

相似文献

1
SIGLEC1 (CD169) as a potential diagnostical screening marker for monogenic interferonopathies.信号淋巴细胞激活分子家族成员1（CD169）作为单基因干扰素病的潜在诊断筛查标志物。
Pediatr Allergy Immunol. 2021 Apr;32(3):621-625. doi: 10.1111/pai.13400. Epub 2020 Nov 9.
2
SIGLEC1 (CD169) is a sensitive biomarker for the deterioration of the clinical course in childhood systemic lupus erythematosus.SIGLEC1（CD169）是儿童系统性红斑狼疮临床病程恶化的敏感生物标志物。
Lupus. 2020 Dec;29(14):1914-1925. doi: 10.1177/0961203320965699. Epub 2020 Oct 20.
3
Reduced number of CD169 macrophages in pre-metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patients.在动物模型中，转移前区域淋巴结中CD169巨噬细胞数量减少与随后的转移性疾病相关，并且与前列腺癌患者的不良预后相关。
Prostate. 2017 Nov;77(15):1468-1477. doi: 10.1002/pros.23407. Epub 2017 Sep 7.
4
CD169 macrophages are critical for osteoblast maintenance and promote intramembranous and endochondral ossification during bone repair.CD169 巨噬细胞对于成骨细胞的维持至关重要，并在骨修复过程中促进膜内和软骨内成骨。
Biomaterials. 2019 Mar;196:51-66. doi: 10.1016/j.biomaterials.2017.10.033. Epub 2017 Oct 22.
5
MiR-195-5p inhibits the development of chronic obstructive pulmonary disease via targeting siglec1.miR-195-5p 通过靶向 Siglec1 抑制慢性阻塞性肺疾病的发展。
Hum Exp Toxicol. 2020 Oct;39(10):1333-1344. doi: 10.1177/0960327120920923. Epub 2020 Apr 30.
6
CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity.CD169/SIGLEC1在新冠病毒疾病（COVID-19）的循环单核细胞上表达，其表达水平与疾病严重程度相关。
Infection. 2021 Aug;49(4):757-762. doi: 10.1007/s15010-021-01606-9. Epub 2021 Apr 6.
7
Polymorphisms in SIGLEC1 contribute to susceptibility to pulmonary active tuberculosis possibly through the modulation of IL-1ß.SIGLEC1 多态性可能通过调节 IL-1β 导致肺结核易感性。
Infect Genet Evol. 2017 Nov;55:313-317. doi: 10.1016/j.meegid.2017.09.031. Epub 2017 Sep 28.
8
The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.CD169阳性淋巴结巨噬细胞在乳腺癌患者中的临床意义
PLoS One. 2016 Nov 18;11(11):e0166680. doi: 10.1371/journal.pone.0166680. eCollection 2016.
9
Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma.CD169+ 淋巴结窦状隙巨噬细胞对恶性黑色素瘤患者的预后意义。
Cancer Immunol Res. 2015 Dec;3(12):1356-63. doi: 10.1158/2326-6066.CIR-14-0180. Epub 2015 Aug 21.
10
SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome.唾液酸结合免疫球蛋白样凝集素1（SIGLEC1）是疾病活动的生物标志物，提示原发性干燥综合征的腺外表现。
RMD Open. 2016 Dec 30;2(2):e000292. doi: 10.1136/rmdopen-2016-000292. eCollection 2016.

引用本文的文献

1
Significant Reduction of Lung Disease on Baricitinib Therapy in a Patient With COPA Syndrome.巴瑞替尼治疗COPA综合征患者可显著减轻肺部疾病
Pediatr Pulmonol. 2025 Jan;60(1):e27423. doi: 10.1002/ppul.27423. Epub 2024 Nov 27.
2
Understanding neurodevelopmental proteasomopathies as new rare disease entities: A review of current concepts, molecular biomarkers, and perspectives.将神经发育蛋白酶体病理解为新型罕见病实体：当前概念、分子生物标志物及展望综述
Genes Dis. 2023 Sep 26;11(6):101130. doi: 10.1016/j.gendis.2023.101130. eCollection 2024 Nov.
3
Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer.
鉴定结直肠癌中的坏死性凋亡相关亚型，构建新的signature，并分析免疫浸润特征。
Front Immunol. 2022 Dec 5;13:999084. doi: 10.3389/fimmu.2022.999084. eCollection 2022.
4
Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease.髓系CD169/唾液酸结合免疫球蛋白样凝集素1：病毒疾病中的一种免疫调节生物标志物。
Front Med (Lausanne). 2022 Sep 23;9:979373. doi: 10.3389/fmed.2022.979373. eCollection 2022.
5
SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity.严重和致命的新型冠状病毒肺炎（COVID-19）中，原发性抗体缺陷患者无特异性体液免疫时的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）T细胞反应
Front Immunol. 2022 Mar 10;13:840126. doi: 10.3389/fimmu.2022.840126. eCollection 2022.
6
SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies.SIGLEC1 可直接评估特发性炎性肌病的 I 型干扰素活性。
RMD Open. 2022 Feb;8(1). doi: 10.1136/rmdopen-2021-001934.
7
SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients.SIGLEC1（CD169）：多发性硬化症患者大脑中活跃的神经炎症标志物，但不在血液中。
Sci Rep. 2021 May 13;11(1):10299. doi: 10.1038/s41598-021-89786-0.
8
Role of Proteasomes in Inflammation.蛋白酶体在炎症中的作用。
J Clin Med. 2021 Apr 20;10(8):1783. doi: 10.3390/jcm10081783.
9
CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity.CD169/SIGLEC1在新冠病毒疾病（COVID-19）的循环单核细胞上表达，其表达水平与疾病严重程度相关。
Infection. 2021 Aug;49(4):757-762. doi: 10.1007/s15010-021-01606-9. Epub 2021 Apr 6.